Look for them in the Featured ePoster track in the ePoster Gallery on the Virtual conference website and listen to the authors’ short audio presentations.

To find these 10 best e-Posters, type “Featured ePosters” in the search bar of the e-Poster Gallery.

Congratulations to the winners of the best e-Poster award!

• TARGETING HUMAN PAPILLOMAVIRUS PROMOTER REGIONS AS A POTENTIAL ANTIVIRAL STRATEGY
  Mr. Josué Carvalho, Portugal
• GENOME-WIDE DNA METHYLATION PROFILING IDENTIFIES TWO NOVEL GENES IN CERVICAL NEOPLASIA
  Dr. Mariam El-Zein, Canada
• LONG-TERM CERVICAL CANCER RISK FOLLOWING HPV INFECTION – 28 YEAR FOLLOW-UP OF THE MANCHESTER COHORT
  Ms. Clare Gilham, United Kingdom
• THE PAST, PRESENT AND FUTURE IMPACT OF HIV PREVENTION AND CONTROL ON HPV AND CERVICAL CANCER IN TANZANIA: A MODELLING STUDY
  Ms. Michaela Hall, Australia
• ATOMIC RESOLUTION CRYOEM STRUCTURE OF HPV16 REVEALS CAPSID FLEXIBILITY AND L2 RESIDUES ADJACENT TO CONSERVED L1 REGION
  Ms. Samantha Hartmann, United States
• EXTENDED IMMUNOGENICITY OF THE QUADRIVALENT HPV VACCINE IN A COHORT OF GIRLS LIVING WITH HIV
  Ms. Elisabeth McClymont, Canada
• SQZ-PBMC-HPV, AN INNOVATIVE, AUTOLOGOUS THERAPEUTIC HPV-16 CANCER VACCINE ENGINEERED BY MICROFLUIDIC CELL SQUEEZING TO ELICIT ROBUST CD8+ T CELL RESPONSES
  Dr. Oliver Rosen, United States
• IN VIVO MODEL FOR PAPILLOMAVIRUS INFECTION AND PREVENTION OF TRANSMISSION AND EFFECTIVE DISINFECTION
  Dr. Taylor Saunders-Wood, United Kingdom
• HIGH PREVALENCE AND CONCORDANCE OF ANAL AND CERVICAL HPV GENOTYPES
  Ms. Sarah Thies, Germany
• HAS HPV VACCINATION PREVENTED ADVERSE PREGNANCY OUTCOMES? POPULATION LEVEL ANALYSIS AFTER EIGHT YEARS OF A NATIONAL HPV VACCINATION PROGRAM IN AUSTRALIA
  Dr. Susan Yuill, Australia